Shandong Buchang Pharmaceuticals Co.,Ltd.’s Net Profit Dropped 12.8% in First Half of 2023

Shandong Buchang Pharmaceuticals Co.,Ltd. (山东步长制药股份有限公司) (603858.SH) reported a net profit of 683.6 million yuan in the first half of 2023, down 12.8% year-on-year.

Meanwhile, the company posted 7 billion yuan in revenue, down 2% year-on-year.

At the end of the reporting period, it had 22.5 billion yuan in total assets and 10.6 billion yuan in total liabilities, with a liability-to-asset ratio of 47.1%.